Geovax Labs, Inc.: 5%+ holders

As of November 10, 2026, Geovax Labs, Inc. has Schedule 13D or 13G filings on record, none whose latest reports a stake of 5% or more. 15 filings are on record since July 7, 2025 (Schedule 13G/A, August 14, 2026).

Ayrton Capital LLC also filed stake reports on 31 other companies ↓

Sell to companies like Geovax Labs, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Your website Find my buyers

Opens in a new tab. No signup.

Key facts

• Filing 2026-08-14 · Reporting person: Armistice Capital, LLC · Sole voting: 0 · Shared voting: 387,038 · Sole dispositive: 0 · Shared dispositive: 387,038 · SCHEDULE 13G/A, 2026-08-14
• Filing 2026-08-13 · Reporting person: Mitchell P. Kopin · Sole voting: 0 · Shared voting: 273,657 · Sole dispositive: 0 · Shared dispositive: 273,657 · SCHEDULE 13G/A, 2026-08-13
• Filing 2026-08-13 · Reporting person: Ayrton Capital LLC · Sole voting: 118,715 · Shared voting: 0 · Sole dispositive: 118,715 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-08-13
• Filing 2026-08-10 · Reporting person: Jane Street Group, LLC · Sole voting: 0 · Shared voting: 315,275 · Sole dispositive: 0 · Shared dispositive: 315,275 · SCHEDULE 13G/A, 2026-08-10
• Filed 2026-06-09 · Holder: Jane Street Group, LLC · Percent: 5.6% · SCHEDULE 13G

Geovax Labs, Inc. has 15 Schedule 13D or 13G filings on record since 2025-07-07. No holder's latest filing reports 5% or more. Each figure below is the holder's own, as filed, with the filing linked.

Holders

Swipe the table sideways to see every column.

Holding shares or following this stake? See who's behind Geovax Labs, Inc. and the warning signs.

See Geovax Labs, Inc.'s free Snapshot Watch Geovax Labs, Inc.: email me the next time it files something

Free to see. No signup.

Keep reading

More on Geovax Labs, Inc. and the records around it.

Geovax Labs, Inc. elsewhere on the record

• Leadership changes Oct 2026
• Who owns it

Companies that share a holder

• Ayrton Capital LLC also filed stake reports on 31 other companies: Bluejay Diagnostics, Inc. (Aug 2026), BTC Digital Ltd. (Aug 2026), DEFSEC Technologies Inc. (Aug 2026)
• L1 Capital Global Opportunities Master Fund, Ltd. also filed stake reports on 42 other companies: Youlife Group Inc. (Nov 2026), INLIF Ltd (Oct 2026), DarkIris Inc. (Oct 2026)
• Mitchell P. Kopin also filed stake reports on 55 other companies: SCWorx Corp. (Sep 2026), NFT Limited (Aug 2026), Silexion Therapeutics Corp (Aug 2026)

Want the whole picture on Geovax Labs, Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Geovax Labs, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Geovax Labs, Inc. covers

1. The Short Answer

2. Which Company This Is

3. What They Do, And How The Money Works

4. Who Runs It, And How To Reach Them

5. The Money: Funding, Valuation, Runway

6. Who Pays Them, And Who They Are Up Against

7. Warning Bells

8. Sources

   18 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

Order Full ReportSee a sample report

A real finished report, first screen. Opens in a new tab.

Voting and dispositive power, as filed

Swipe the table sideways to see every column.

The latest filing identifies Geovax Labs, Inc. by CUSIP 373678705 and gives its principal executive office as 1900 Lake Park Drive, Suite 380, Smyrna, GA 30080 (SCHEDULE 13G/A, 2026-08-14).

What the percentages are based on

The percentages below are based on (i) 7,369,243 shares of Common Stock of the Issuer that were outstanding as of July 27, 2026; and (ii) 118,715 shares of Common Stock issuable on the exercise of the Warrants held by the Reporting Persons. The amount of shares outstanding was based upon a statement in the Issuer's 10-Q filed on July 27, 2026.Ayrton Capital LLC, SCHEDULE 13G/A, 2026-08-13

Timeline

Swipe the table sideways to see every column.

Also on the record for Geovax Labs, Inc.

Swipe the table sideways to see every column.

Tools for this story

Each opens in a new tab, filled in for Geovax Labs, Inc.. With no account yet, you sign up free and land on the result.

• Get an alert when Geovax Labs, Inc. is mentioned again
• Find former Geovax Labs, Inc. employees to interview
• Verify a claim or statistic

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

All recent stakesThat week's stakes